The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Some people with small-cell lung cancer get Cushing's syndrome. The cancer may tell your body to make a hormone called ACTH, which raises the level of cortisol. This leads to fluid retention and ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Patients with small-cell lung cancer might experience weight gain as the cancer can cause the body to produce ACTH, a hormone that increases cortisol levels and encourages fluid retention ...

Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, Amgen is further proving the drug's worth with overall survival data ...

Trial results will inform potential marketing approval application in non-small cell lung cancer, one of the largest indications in oncology SYDNEY, AUSTRALIA, March 25, 2025 (GLOBE NEWSWIRE ...